Navigation Links
Anything but modest: The mouse continues to contribute to humankind
Date:8/7/2008

Cambridge, UK, 07 August 2008 - "Big things come in small packages," the saying goes, and it couldn't be more true when discussing the mouse. This little creature has become a crucial part of human history through its contributions in understanding human genetics and disease. In a review published in Disease Models & Mechanisms (DMM), http://dmm.biologists.org, genetics researchers from Yale University School of Medicine and Fudan University School of Life Sciences discuss the history and future of mice as a model organism. They predict that the next frontiers in mouse genetics such as creating mice expressing human genes to create "humanized" mice will continue to provide scientists with new tools to not only decipher clinical mysteries, but also to test novel therapies and cures.

The review's authors, Duc Nguyen and Tian Xu, discuss the many ways in which scientists manipulate mouse genes in order to study their biology. One such technique that Nguyen and Xu are working on involves inserting a segment of DNA sequence into the much lengthier full genome of the mouse. These insertable DNA sequences are known as transposons. Use of transposons, as well as other genetic tools, allows scientists to disrupt a specific mouse gene and deduce the gene's function by studying the effect on the mouse. The hope is that the research community can combine the results of extensive mouse studies into a comprehensive library to form a functional map of the mouse genome. Such a map will help researchers navigate and explore the even more extensive human genome to pinpoint the genetic underpinnings of human disease.

Not only do the researchers discuss how mice help us understand disease, but they also highlight methods which enable research of novel disease therapies. For example, humanized mice mice engineered to carry human genes can provide new experimental systems for testing new therapeutics.


'/>"/>

Contact: Donna Perry
donna@biologists.com
44-122-342-6164
The Company of Biologists
Source:Eurekalert

Page: 1

Related biology news :

1. A computer for your mouse!
2. Immune cells promote blood vessel formation in mouse endometriosis
3. Cancer-resistant mouse discovered
4. Looking through the eyes of a mouse, scientists monitor circulating cells in its bloodstream
5. New chimeric mouse model for human liver diseases, drug testing
6. CSHL scientists identify and repress breast cancer stem cells in mouse tissue
7. Dissecting the genetic components of adaptation of E. coli to the mouse gut
8. Book is the first high-resolution digital mouse brain atlas designed for Web applications
9. Scientists successfully treat new mouse model of inflammatory bowel disease
10. Negligent, attentive mouse mothers show biological differences
11. Mouse study: When it comes to living longer, its better to go hungry than go running
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 19, 2017 Sensory Inc ... and security for consumer electronics, and i ... systems and cybersecurity solutions, today announced a global ... financial institutions worldwide to bolster security of data ... secure user authentication platforms they offer, innerCore now ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... , Jan. 5, 2017  SomaLogic announced today ... Life Alliance" established by iCarbonX, the ... build a "Global Digital Health Ecosystem that can ... combination of individual,s biological, behavioral and psychological data, ... between the companies, SomaLogic will provide proteomics data ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... N.J. , Jan. 23, 2017   Enteris ... feasibility study agreement with Sanofi to leverage ... delivery platform, Peptelligence™, to develop an oral formulation of ... Joel Tune , Chief Executive Officer and Executive ... is further validation of the tremendous value our Peptelligence ...
(Date:1/23/2017)... , Jan. 23, 2017  Alkahest Inc. ... treatments for neurodegenerative diseases and other age-related conditions, ... the company as Chief Medical Officer. In this ... clinical development activities at Alkahest and serve on ... most recently served as Executive Director at Dynavax, ...
(Date:1/21/2017)... ... January 20, 2017 , ... Nipro Corporation (Osaka, Japan) and Transonic ... which Nipro will receive exclusive marketing and sales rights for all non-OEM Transonic products ... hemodialysis patients in Japan, the new Nipro - Transonic JV is a natural next ...
(Date:1/21/2017)... Jan. 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... on the licensing, development and commercialization of innovative biopharmaceutical ... Best Company in North America ... award based on the FDA approval of three ... ENTYCE ® (capromorelin oral solution) and NOCITA ® ...
Breaking Biology Technology: